📰 Breaking News: Lessons Learnt & Insights from UK’s first and to date only SME Restructuring Plan

Oxford Biocitech Holdings Limited enters members' voluntary liquidation

Active Company no. 13929455 Incorporated Feb 2022 Real Estate KT postcode area

Companies House record →

Unit 2 Spinnaker Court 1c Becketts Place, Hampton Wick, Kingston Upon Thames, KT1 4EQ

The most recent insolvency notice for Oxford Biocitech Holdings Limited is a Resolution for winding up (MVL), published 20 November 2026 in The London Gazette. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Last filed balance sheet

Not yet retrieved.

Insolvency notices (3)

  1. The notice announces that Oxford Biocitech Holdings Limited has passed a resolution to wind up the company by members’ voluntary liquidation.

  2. The notice announces the appointment of Andrew John Whelan as liquidator for OXFORD BIOCITECH HOLDINGS LIMITED in a members voluntary liquidation.

  3. Creditors of Oxford Biocitech Holdings Limited are required to submit their claims by 21 December 2026 as the company is being wound up solvently for distribution to shareholders.

Follow Oxford Biocitech Holdings Limited

Get an email when The London Gazette publishes the next notice for this company: a creditors' meeting, an appointment, a winding-up order, a dividend, or the close of the process. Free, and you can stop it with one click.

What happens next

Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.

Owed money by Oxford Biocitech Holdings Limited?

A bad debt this size rarely stops with the company that failed. If you're a supplier or creditor left short, it's worth knowing where you rank — and checking what the shortfall does to your own cashflow.

Related guidance

Closing a company of your own? Get a fixed-fee liquidation quote.

Frequently asked questions

Is Oxford Biocitech Holdings Limited in financial difficulty?

No — the most recent process is a solvent one. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The most recent insolvency notice for Oxford Biocitech Holdings Limited (company no. 13929455) is a Resolution for winding up (MVL), published 20 November 2026 in The London Gazette.

What were Oxford Biocitech Holdings Limited's last filed accounts?

Not yet retrieved for Oxford Biocitech Holdings Limited at Companies House.

How many insolvency notices does Oxford Biocitech Holdings Limited have?

Oxford Biocitech Holdings Limited has 3 insolvency notices recorded in The London Gazette, the most recent being a Resolution for winding up (MVL) on 20 November 2026.

What happens next?

Because this is a solvent liquidation, creditors are paid in full. The liquidator advertises for claims, settles them, distributes the surplus to the shareholders and the company is then dissolved. Anyone owed money should still submit their claim to the liquidator named in the notice, and within the period the notice states.

Financial figures are taken from the company's own last accounts filed at Companies House. Small and micro-entity accounts are unaudited, and for a company entering an insolvency process the most recent filing frequently predates that process by a year or more. Figures are indicative and are not a valuation. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright.